In adults hospitalized with COVID-19, adding baricitinib vs. dexamethasone to remdesivir did not differ for MV-free survival
Authors: Alexandre Tran, Bram Rochwerg
Published: 2022-10-03
DOI:
10.7326/j22-0074
Source:
Full article
Abstract
No abstract found.